These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 15569507

  • 1. [Calculation of the combined renal dysfunction risk in patients co-exposed to arsenicum and cadmium by using benchmark dose method].
    Hong F, Jin TY, Zhang AH.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Nov; 38(6):374-8. PubMed ID: 15569507
    [Abstract] [Full Text] [Related]

  • 2. Biomarkers of cadmium and arsenic interactions.
    Nordberg GF, Jin T, Hong F, Zhang A, Buchet JP, Bernard A.
    Toxicol Appl Pharmacol; 2005 Aug 07; 206(2):191-7. PubMed ID: 15967208
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Critical exposure level of cadmium for elevated urinary metallothionein--an occupational population study in China.
    Chen L, Jin T, Huang B, Nordberg G, Nordberg M.
    Toxicol Appl Pharmacol; 2006 Aug 15; 215(1):93-9. PubMed ID: 16510161
    [Abstract] [Full Text] [Related]

  • 5. Risk assessment on renal dysfunction caused by co-exposure to arsenic and cadmium using benchmark dose calculation in a Chinese population.
    Hong F, Jin T, Zhang A.
    Biometals; 2004 Oct 15; 17(5):573-80. PubMed ID: 15688868
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Estimation of benchmark dose for renal dysfunction in a cadmium non-polluted area in Japan.
    Kobayashi E, Suwazono Y, Uetani M, Inaba T, Oishi M, Kido T, Nishijo M, Nakagawa H, Nogawa K.
    J Appl Toxicol; 2006 Oct 15; 26(4):351-5. PubMed ID: 16791912
    [Abstract] [Full Text] [Related]

  • 8. [Application of Benchmark dose (BMD) in estimating biological exposure limit (BEL)].
    Shao B, Jin TY, Qian HL, Wu XW, Kong QH, Ye TT.
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Jan 15; 24(1):20-2. PubMed ID: 16600088
    [Abstract] [Full Text] [Related]

  • 9. Estimation of benchmark dose as the threshold levels of urinary cadmium, based on excretion of total protein, beta2-microglobulin, and N-acetyl-beta-D-glucosaminidase in cadmium nonpolluted regions in Japan.
    Kobayashi E, Suwazono Y, Uetani M, Inaba T, Oishi M, Kido T, Nishijo M, Nakagawa H, Nogawa K.
    Environ Res; 2006 Jul 15; 101(3):401-6. PubMed ID: 16436274
    [Abstract] [Full Text] [Related]

  • 10. [Renal dysfunction in workers exposed to arsenic and cadmium].
    Hong F, Jin TY, Lu GD, Yin ZY.
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2003 Dec 15; 21(6):432-6. PubMed ID: 14761355
    [Abstract] [Full Text] [Related]

  • 11. [Application of benchmark dose (BMD) in a bone-effect study on a general population environmentally exposed to cadmium].
    Qian HL, Jin TY, Kong QH, Wang HF, Zhu GY.
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Jan 15; 24(1):23-6. PubMed ID: 16600089
    [Abstract] [Full Text] [Related]

  • 12. Estimation of the benchmark dose of urinary cadmium as the reference level for renal dysfunction: a large sample study in five cadmium polluted areas in China.
    Ke S, Cheng XY, Zhang JY, Jia WJ, Li H, Luo HF, Ge PH, Liu ZM, Wang HM, He JS, Chen ZN.
    BMC Public Health; 2015 Jul 14; 15():656. PubMed ID: 26169263
    [Abstract] [Full Text] [Related]

  • 13. Estimation of benchmark dose for bone damage and renal dysfunction in a Chinese male population occupationally exposed to lead.
    Sun Y, Sun D, Zhou Z, Zhu G, Lei L, Zhang H, Chang X, Jin T.
    Ann Occup Hyg; 2008 Aug 14; 52(6):527-33. PubMed ID: 18567606
    [Abstract] [Full Text] [Related]

  • 14. Reassessment of the threshold of urinary cadmium by using hybrid approach in a cadmium non-polluted area in Japan.
    Suwazono Y, Nogawa K, Uetani M, Kido T, Nakagawa H.
    Int J Hyg Environ Health; 2011 Mar 14; 214(2):175-8. PubMed ID: 20889376
    [Abstract] [Full Text] [Related]

  • 15. Effects of low-dose cadmium exposure on biological examinations.
    Nakadaira H, Nishi S.
    Sci Total Environ; 2003 Jun 01; 308(1-3):49-62. PubMed ID: 12738200
    [Abstract] [Full Text] [Related]

  • 16. Benchmark dose approach for renal dysfunction in workers exposed to lead.
    Lin T, Tai-Yi J.
    Environ Toxicol; 2007 Jun 01; 22(3):229-33. PubMed ID: 17497640
    [Abstract] [Full Text] [Related]

  • 17. Application of the Benchmark Dose (BMD) Method to Identify Thresholds of Cadmium-Induced Renal Effects in Non-Polluted Areas in China.
    Wang X, Wang Y, Feng L, Tong Y, Chen Z, Ying S, Chen T, Li T, Xia H, Jiang Z, Shang Q, Lou X, Lou J.
    PLoS One; 2016 Jun 01; 11(8):e0161240. PubMed ID: 27537182
    [Abstract] [Full Text] [Related]

  • 18. Renal effects evolution in a Chinese population after reduction of cadmium exposure in rice.
    Wu X, Liang Y, Jin T, Ye T, Kong Q, Wang Z, Lei L, Bergdahl IA, Nordberg GF.
    Environ Res; 2008 Oct 01; 108(2):233-8. PubMed ID: 18692183
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of kidney dysfunction in humans - relationship to cadmium dose, metallothionein, immunological and metabolic factors.
    Nordberg GF, Jin T, Wu X, Lu J, Chen L, Lei L, Hong F, Nordberg M.
    Biochimie; 2009 Oct 01; 91(10):1282-5. PubMed ID: 19563860
    [Abstract] [Full Text] [Related]

  • 20. Estimation of benchmark doses as threshold levels of urinary cadmium, based on excretion of beta2-microglobulin in cadmium-polluted and non-polluted regions in Japan.
    Kobayashi E, Suwazono Y, Dochi M, Honda R, Nishijo M, Kido T, Nakagawa H.
    Toxicol Lett; 2008 Jun 30; 179(2):108-12. PubMed ID: 18515022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.